Fibrostenotic Crohn’s disease research hub

A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time

This study is looking into a new medication called AGMB-129 for Crohn's disease. It's a very early-stage trial checking if the medication is safe for healthy adults when given in small, increasing doses.

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

An Open-Label, Fixed-Sequence, Drug-Drug Interaction Study in Healthy Participants to Evaluate the Effect of AGMB-129 on the Pharmacokinetics of Midazolam, a Sensitive Index Substrate of CYP3A4